Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Hirschsprung Disease: early-phase trial registry

1 of 3 indexed Hirschsprung Disease trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Hirschsprung Disease: 3 US clinical trials tracked, 1 recruiting.

Hirschsprung Disease is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is NYU Langone Health, running 1 of these trials.

Enrollment posture brief

Registry condition hirschsprung-disease

OPEN 1 | RECR 33% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Hirschsprung Disease (this)33%
Open-enrollment share among volume-matched conditions near Hirschsprung Disease

Hirschsprung Disease lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Hirschsprung Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Hirschsprung Disease is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21

Phase Distribution

PhaseTrial count
Phase 2 1

Named interventions

Most-linked intervention names on Hirschsprung Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

VSL#3 Drug
1 trials
Endoscopic mucosal resection (EMR) Procedure
1 trials
Identification of genetic causes of Hirschsprung Disease Other
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on Hirschsprung Disease trials. A trial with sites in several states counts in each.

New York 2 trials
Michigan 1 trials
Massachusetts 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Hirschsprung Disease page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Hirschsprung Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • NYU Langone Health sponsors the most Hirschsprung Disease trials on record, review their full trial history before evaluating a specific study. See NYU Langone Health's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hirschsprung Disease condition card totals 3 registered trials; most-linked intervention VSL#3; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.